One-Alpha Capsules 1 µg, 0,25 µg CAPSULES
PDF Leaflet Revision Date: 13 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of renal bone disease, hypoparathyroidism, and related conditions.
Dosage (summary)
Adults: 1 u03bcg daily; adjust based on response. Children: 0.05 u03bcg/kg daily.
Onset of Action / Duration
Onset: 3 days, Duration: Varies.
Special Populations
- Renal impairment
- Children
- Pregnant women
Pregnancy & Breastfeeding
Not recommended in pregnancy; excreted in breast milk.
Key Drug Interactions
- Thiazide diuretics
- Other vitamin D preparations
- Anticonvulsants
Contraindications
- Hypersensitivity
- Hypercalcaemia
- Vitamin D intoxication
- First trimester of pregnancy
Common side effects
- Hypercalcaemia
- Rash
- Gastrointestinal discomfort
- Hyperphosphataemia
Counselling Points
- Monitor for signs of hypercalcaemia
- Avoid concurrent vitamin D
- Take with caution if using thiazides
Serious warnings
- Risk of hypercalcaemia
- Monitor calcium levels
- Caution in renal impairment
Important Disclaimer
The One-Alpha Capsules 1 µg, 0,25 µg CAPSULES professional information leaflet below is the property of Adcock Ingram Critical Care and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
